145 related articles for article (PubMed ID: 37652517)
21. Preoperative Risk Stratification of Endometrial Carcinoma: L1CAM as a Biomarker.
Pasanen A; Loukovaara M; Tuomi T; Bützow R
Int J Gynecol Cancer; 2017 Sep; 27(7):1318-1324. PubMed ID: 29059097
[TBL] [Abstract][Full Text] [Related]
22. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression.
Park S; Cho Y; Kim HS
Anticancer Res; 2023 Oct; 43(10):4559-4571. PubMed ID: 37772557
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of p53 expression in early stage cervical carcinoma treated by surgery.
Khunamornpong S; Siriaunkgul S; Manusirivithaya S; Settakorn J; Srisomboon J; Ponjaroen J; Thorner PS
Asian Pac J Cancer Prev; 2008; 9(1):48-52. PubMed ID: 18439073
[TBL] [Abstract][Full Text] [Related]
24. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
25. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients.
Wang YY; Li L; Zhao ZS; Wang YX; Ye ZY; Tao HQ
J Exp Clin Cancer Res; 2013 Sep; 32(1):66. PubMed ID: 24422715
[TBL] [Abstract][Full Text] [Related]
26. Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
Kommoss S; Hartkopf AD; Krämer B; Bunz AK; Grevenkamp F; Kommoss F; Pasternak J; Arbabi SM; Wallwiener M; Staebler A; Lax SF; Brucker SY; Taran FA
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2183-2188. PubMed ID: 28710714
[TBL] [Abstract][Full Text] [Related]
27. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
28. L1CAM and HER2 Expression in Early Endometrioid Uterine Cancer.
Abdel Azim S; Sprung S; Mutz-Dehbalaie I; Fessler S; Zeimet AG; Marth C
Int J Gynecol Pathol; 2017 Jul; 36(4):356-363. PubMed ID: 28221216
[TBL] [Abstract][Full Text] [Related]
29. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
van der Putten LJM; Visser NCM; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Werner HMJ; Amant F; Massuger LFAG; Pijnenborg JMA
Int J Gynecol Cancer; 2018 Mar; 28(3):514-523. PubMed ID: 29324536
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer.
Ichikawa T; Okugawa Y; Toiyama Y; Tanaka K; Yin C; Kitajima T; Kondo S; Shimura T; Ohi M; Araki T; Kusunoki M
Br J Cancer; 2019 Dec; 121(12):1058-1068. PubMed ID: 31754264
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer.
Kim J; Kim SI; Kim NR; Kim H; Kim HS; Chung HH; Kim JW; Lee C; Lee M
Gynecol Oncol; 2023 Jul; 174():231-238. PubMed ID: 37236032
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
33. L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.
van der Putten LJ; Visser NC; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MP; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Amant F; Massuger LF; Pijnenborg JM
Br J Cancer; 2016 Sep; 115(6):716-24. PubMed ID: 27505134
[TBL] [Abstract][Full Text] [Related]
34. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
Yan M; Zhang YN; He JH; Sun JR; Sun XM
Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
[TBL] [Abstract][Full Text] [Related]
35. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
36. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
37. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
[TBL] [Abstract][Full Text] [Related]
38. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
40. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]